PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for July 7, 2006 Subscribe to this News Feed    
 

ThinSpring Was Selected To Demonstrate PIM Server To The European Federation Of Pharmaceutical Industries Associates (EFPIA) In Brussels On June 14, 2006

ThinSpring was selected to demonstrate PIM Server™ to the European Federation of Pharmaceutical Industries and Associations (EFPIA) in Brussels on June 14, 2006. This meeting was a direct result of an increased interest on the part of European regulatory bodies to require electronic file format for all labeling submissions.

Brussels, Belgium (PRWEB) July 7, 2006 -- ThinSpring, a leading provider of XML-based solutions such as SPL Server™ and the Electronic Labeling Information Processing System (ELIPS) for the United States Food and Drug Administration (FDA), was selected to demonstrate PIM Server™ to the European Federation of Pharmaceutical Industries and Associations (EFPIA) in Brussels on June 14, 2006. This meeting was a direct result of an increased interest on the part of European regulatory bodies to require electronic file format for all labeling submissions.

ThinSpring presented the key features of PIM Server, demonstrated the software, and allowed time for Q&A. ThinSpring demonstrated a solution that answered the key issues facing the EFPIA, one of which was the elimination of redundancy through data reuse. Other aspects of the ThinSpring solution that were demonstrated included distributed data entry, check-in/check-out, process management, advanced editing, and multilingual capability. Users were able to operate SPL Server with absolutely no XML or HTML knowledge.

The FDA currently uses ELIPS as a part of the process to internally validate Structured Product Label (SPL) submissions from pharmaceutical manufacturers. The FDA made SPL mandatory as of November 3, 2005. Shortly after that in December of 2005, the European Medicines Agency (EMEA) saw the first use of its Product Information Management (PIM) system.

For more information about PIM Server, go to the ThinSpring website or contact Ron Celeste at (908) 595-2145.

About ThinSpring:
ThinSpring, founded by former pharmaceutical and medical device professionals, specializes in XML-based Web service solutions, integration and data conversion. ThinSpring has used its industry expertise to develop a dynamic XML engine, MatriXML™. This patented XML technology is the basis for SPL Server™. ThinSpring’s solutions have gained acceptance as an essential, collaborative application-development platform for FDA regulated companies. ThinSpring’s core team manages technology and regulatory consulting divisions that support its clients’ operations throughout the United States, Europe, Asia and South America. ThinSpring headquarters is in Bridgewater, New Jersey, with offices in California and North Carolina. More information about ThinSpring and ThinSpring SPL Server™, can be found on their website at: http://www.ThinSpring.com.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/RmFsdS1aZXRhLUNvdXAtRW1wdC1JbnNlLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Ron Celeste
THINSPRING
908-595-2145
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.